乳腺X线及MRI特征联合临床病理预测乳腺导管原位癌伴微浸润OA北大核心CSTPCD
Combining the X-ray and MRI characteristics with the clinical pathology to predict ductal carcinoma in situ with microinvasion of breast
目的 探讨基于临床病理、乳腺X线(mammography,MG)和MRI特征预测乳腺导管原位癌伴微浸润(ductal carcinoma in situ with microinvasion,DCISM)的价值.材料与方法 回顾性收集宁夏医科大学总医院2019年6月至2022年6月最终经手术病理证实为纯导管原位癌(ductal carcinoma in situ,DCIS)和DCISM的首诊女性患者的病例资料为训练组,评估术前患者的临床病理、MG和MRI特征.采用单、多因素logistic回归分析明确DCISM的独立危险因素,并建立联合模型.通过受试者工作特征(receiver operating characteristic,ROC)曲线下面积(area under the curve,AUC)及校准图评估模型的诊断效能,应用决策曲线分析(decision curve analysis,DCA)观察联合模型的临床实用性.前瞻性收集2022年7月至2023年7月符合纳入、排除标准的患者作为验证组进行验证.应用沙普利加和解释(Shapley Additive exPlanation,SHAP)分析联合模型中病灶最长径、核级别、坏死、Ki-67指数、P63状态、钙化状态和最小ADC值(minimum value of apparent diffusion coefficient,ADCmin)预测DCISM的价值.收集535例患者共550个病灶(15例患者为同时性双乳癌),患者年龄23~81岁,中位年龄50岁.训练组(n=382)中102个病灶(27%)和验证组(n=168)中52个病灶(31%)被诊断为DCISM.结果 多因素logistic回归结果显示,病灶最长径、核级别、坏死、Ki-67指数、P63状态、钙化状态和ADCmin是DCISM的独立危险因素.基于上述参数构建临床病理及联合模型,在训练组和验证组中均表现出较高的预测效能(AUC:0.937、0.899).根据SHAP分析,病灶最长径、Ki-67指数和ADCmin在联合模型中对预测DCISM起主要贡献,而钙化状态、核级别、P63状态和坏死是补充因素.结论 联合临床病理及术前MG和MRI特征的预测模型可有效从纯DCIS区分出DCISM,从而提升临床决策和治疗规划的准确性.
Objective:To explore the value of clinical-pathological,mammographic(MG),and MRI features in predicting ductal carcinoma in situ with microinvasion(DCISM).Materials and Methods:A retrospective study was conducted on female patients diagnosed with pure ductal carcinoma in situ(DCIS)and DCISM confirmed by final surgical pathology from June 2019 to June 2022 at General Hospital of Ningxia Medical University.Clinical-pathological,MG,and MRI features of the patients were evaluated.The univariate and multivariate logistic regression analysis was used to identify independent risk factors for DCISM and develop a combined model.The diagnostic performance of the model was assessed using the area under the receiver operating characteristic(ROC)curve(AUC)and calibration plot.The clinical utility of the combined model was evaluated using decision curve analysis(DCA).A prospective validation was performed on patients who meet the eligibility criteria for inclusion and exclusion from July 2022 to July 2023.Shapley Additive exPlanation(SHAP)analysis was applied to assess the value of the combined model in predicting DCISM based on the longest diameter of the lesion,nuclear grade,necrosis,Ki-67 index,P63 status,calcification status,and minimum ADC value.A total of 535 patients with 550 lesions(15 cases were synchronous bilateral breast cancer)were collected.The patients'ages ranged from 23 to 81 years,with a median age of 50 years.Among the training group(n=382),102 lesions(27%)were diagnosed as DCISM,while in the validation group(n=168),52 lesions(31%)were diagnosed as DCISM.Results:The multivariable logistic regression analysis showed the independent risk factors of DCISM included longest diameter of the lesion,nuclear grade,necrosis,Ki-67 index,P63 status,calcification status,and the minimum value of apparent diffusion coefficient(ADCmin).A predictive model combining the above parameters with preoperative clinical-pathological,mammography,and MRI features was constructed,demonstrating high predictive performance in both the training and validation groups(AUC:0.937,0.899).According to SHAP analysis,the longest diameter of the lesion,Ki-67 index,and ADCmin make the primary contributions in the combined model for predicting DCISM,while the calcification status,nuclear grade,P63 status,and necrosis are supplementary factors.Conclusions:A combined predictive model using clinical-pathological,preoperative MG and MRI features can effectively differentiate DCISM from pure DCIS,thereby improving the accuracy of clinical decision-making and treatment planning.
周晓平;杨蔚;尹清云;张宁妹;张朝林;刘开惠;吴林桦
宁夏医科大学临床医学院,银川 750004宁夏医科大学总医院放射科,银川 750004宁夏医科大学总医院肿瘤内科,银川 750004宁夏医科大学总医院病理科,银川 750004宁夏医科大学总医院肿瘤外科,银川 750004
临床医学
乳腺肿瘤导管原位癌导管原位癌伴微浸润可解释性乳腺X线摄影磁共振成像
breast tumorductal carcinoma in situductal carcinoma in situ with microinvasioninterpretabilitymammographymagnetic resonance imaging
《磁共振成像》 2024 (005)
102-110,118 / 10
Key Research and Development(R&D)Project of the Ningxia Hui Autonomous Region in 2022(No.2022BEG03166). 2022年宁夏回族自治区重点研发计划项目(编号:2022BEG03166)
评论